feed,title,long_url,short_url
Benzinga,"Newly Approved ARS Pharmaceuticals' Needle-Free Neffy Offers Convenience Over EpiPen For Allergic Reaction, But Real-World Efficacy Questioned",https://benzinga.com/general/biotech/24/08/40531242/newly-approved-ars-pharmaceuticals-needle-free-neffy-offers-convenience-over-epipen-for-allergic-,https://da.gd/O0fe4
